Morepen Laboratories (NSE:MOREPENLAB) E10: ₹1.65 (As of Mar. 2026)


NSE:MOREPENLAB Morepen Laboratories Ltd NSE:MOREPENLAB
74 GF Score
Price ₹53.16
GF Value ₹49.82
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Morepen Laboratories E10?

Morepen Laboratories NSE:MOREPENLAB +2.00% 74 E10 is ₹1.65 as of Mar. 2026. GuruFocus rates NSE:MOREPENLAB with a GF Score™ of 74/100 and a GF Value™ of ₹49.82 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Morepen Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹0.280. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹1.65 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Morepen Laboratories's average E10 Growth Rate was 5.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-27), Morepen Laboratories's current stock price is ₹53.16. Morepen Laboratories's E10 for the quarter that ended in Mar. 2026 was ₹1.65. Morepen Laboratories's Shiller PE Ratio of today is 32.22.

During the past 13 years, the highest Shiller PE Ratio of Morepen Laboratories was 61.62. The lowest was 20.59. And the median was 32.57.


Morepen Laboratories  (NSE:MOREPENLAB) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Morepen Laboratories's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=53.16/1.65
=32.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Morepen Laboratories was 61.62. The lowest was 20.59. And the median was 32.57.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Morepen Laboratories E10 Related Terms


Morepen Laboratories E10 Historical Data

* Premium members only.

The historical data trend for Morepen Laboratories's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Morepen Laboratories E10 Chart

Morepen Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 1.58 1.65

Morepen Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.58 1.58 1.64 1.66 1.65

NSE:MOREPENLAB vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Morepen Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Morepen Laboratories Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Morepen Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Morepen Laboratories's Shiller PE Ratio falls into.


NSE:MOREPENLAB
74GF Score
Morepen Laboratories Ltd NSE:MOREPENLAB
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Morepen Laboratories E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Morepen Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.28/164.2724*164.2724
=0.280

Current CPI (Mar. 2026) = 164.2724.

Morepen Laboratories Quarterly Data

per share eps CPI Adj_EPS
201403 0.000 91.425 0.000
201503 0.000 97.163 0.000
201603 0.000 102.518 0.000
201703 0.000 105.196 0.000
201706 0.030 107.109 0.046
201709 0.250 109.021 0.377
201712 0.230 109.404 0.345
201803 0.160 109.786 0.239
201806 0.050 111.317 0.074
201809 0.160 115.142 0.228
201812 0.200 115.142 0.285
201903 0.230 118.202 0.320
201906 0.170 120.880 0.231
201909 0.090 123.175 0.120
201912 0.240 126.235 0.312
202003 0.250 124.705 0.329
202006 0.430 127.000 0.556
202009 0.600 130.118 0.757
202012 0.530 130.889 0.665
202103 0.590 131.771 0.736
202106 0.590 134.084 0.723
202109 0.720 135.847 0.871
202112 0.410 138.161 0.487
202203 0.240 138.822 0.284
202206 0.110 142.347 0.127
202209 0.330 144.661 0.375
202212 0.150 145.763 0.169
202303 0.170 146.865 0.190
202306 0.290 150.280 0.317
202309 0.420 151.492 0.455
202312 0.630 152.924 0.677
202403 0.550 153.035 0.590
202406 0.710 155.789 0.749
202409 0.650 157.882 0.676
202412 0.490 158.323 0.508
202503 0.350 157.552 0.365
202506 0.200 159.755 0.206
202509 0.750 162.289 0.759
202512 0.500 163.281 0.503
202603 0.280 164.272 0.280

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹1.65 mean?
Morepen Laboratories (NSE:MOREPENLAB) has a E10 of ₹1.65 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Morepen Laboratories and its competitors.
Is Morepen Laboratories' E10 too high?
Morepen Laboratories' current E10 is ₹1.65. Overall, Morepen Laboratories has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Morepen Laboratories' E10 compare to ZTS?
Morepen Laboratories' E10 of ₹1.65 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Morepen Laboratories and its competitors. Morepen Laboratories's current E10 is ₹1.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Morepen Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Morepen Laboratories (NSE:MOREPENLAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹49.82, compared to a current price of ₹53.16 — trading 6.7% above its estimated fair value. The current E10 is ₹1.65. Morepen Laboratories' overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Morepen Laboratories (NSE:MOREPENLAB), the current E10 is ₹1.65 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Morepen Laboratories (NSE:MOREPENLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Morepen Laboratories stock appears to be overvalued. The current stock price of ₹53.16 is trading 6.7% above its estimated GF Value™ of ₹49.82. GuruFocus considers Morepen Laboratories to be Fairly Valued.

Key valuation signals for NSE:MOREPENLAB:

  • E10: ₹1.65
  • GF Value™: ₹49.82 vs. price of ₹53.16 (6.7% above fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the NSE:MOREPENLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Morepen Laboratories Business Description

Other Exchanges 500288:India
Address Udyog Vihar-III, Sector-20, 2nd Floor, Tower C, DLF Cyber Park, Gurugram, HR, IND, 122016
Morepen Laboratories Ltd is in the business of manufacturing, producing, developing, and marketing various Active Pharmaceutical Ingredients (APIs), branded and generic formulations, and also Home Health products. Some of the products offered by the company include various drug formulations, APIs, digital thermometers, heat belts, pulse oximeters, nutritional tablets, pain sprays, and others. The company operates in a single segment namely, Pharmaceuticals. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and the Rest of the world.
74GF Score

Get the complete analysis for NSE:MOREPENLAB

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹53.16
Price
₹49.82
GF Value